« Return to News | CROs/Service Providers

Greenphire, Ernst & Young form strategic partnership

Tuesday, July 9, 2013 03:08 PM

Greenphire, a provider of payment technologies for the clinical trials industry, has launched a strategic partnership with Ernst & Young (E&Y) to combine Greenphire’s eClinicalGPS technology with the global intellectual property and expertise of E&Y’s advisory practice for clients in the pharmaceutical industries.

Greenphire’s clients will have access to specialists within E&Y’s global consulting and advisory practice, which focuses on global HCP transparency regulatory compliance (the Sunshine Act). E&Y’s advisory practice will assist Greenphire’s clients in complying with more than 75 transparency regulations globally.

Also, Ernst & Young’s extensive proprietary research will be routed into a new Greenphire technology solution. The technology, currently in development, will be a web-based SAAS solution to manage and track all transactional interactions between pharmaceutical companies and HCPs, including cash transactions and transfers of value, on a global basis across all pharmaceutical operations.

“Global transparency regulations are constantly evolving, and our clients are very much in need of a reliable source of information on how to adjust their processes to remain compliant,” said Sam Whitaker, co-founder and CEO of Greenphire.

“The deep technical knowledge and grounded relationships formed as a result of our long-standing presence in this sector will help clients translate regulation, meet their obligations and gain real insight,” said Martin Holyoake, partner at E&Y.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.